NIH-funded research R21 grant

Understanding coronary artery calcium and its impact on heart disease risk

Official title: Coronary artery calcium synthetic cohort and lifetime percentile project (CACSC-LPP)

Funded at Johns Hopkins University · NIH-10893488 · Data updated 2026-11-12

This study is working on improving a test that measures calcium in your heart arteries to better understand your risk for heart disease, especially for people from different backgrounds, and it will also create a helpful website and app to make it easier for you and your doctor to understand the results.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startAugust 1, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$122,813
NIH project number5R21HL170274-02
Project IDNIH-10893488 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals across a wide age range, particularly younger adults and those from racial/ethnic minorities with increased CVD risk.

Less likely to help

Patients who do not have coronary artery disease or are not at risk for cardiovascular conditions may not benefit from this research.

What this research studies

This research focuses on coronary artery calcium (CAC) testing, which measures the amount of calcium in the coronary arteries and is linked to cardiovascular disease (CVD) risk. The project aims to develop more accurate CAC percentile data that reflects a diverse population, particularly including underrepresented groups like South Asians. Additionally, it will create a centralized resource, including a website and mobile app, to help patients and healthcare providers interpret CAC scores effectively. By addressing these gaps, the research seeks to improve decision-making regarding CVD prevention and treatment.

Why it matters

Potential benefit: If successful, this research could lead to better risk assessment and prevention strategies for heart disease, particularly for diverse populations.

How similar studies have gone: Previous research has shown success in using CAC scoring for cardiovascular risk assessment, but this project aims to expand and diversify the existing data.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Whelton, Seamus Paul — Johns Hopkins University
  • Study coordinator: Whelton, Seamus Paul

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.